The U.S. Food and Drug Administration has just issued draft guidance for postmarket management of cybersecurity of medical devices. The Bio Report spoke to Russell Jones, partner with Deloitte & Touche, cyber risk leader for the firm about the FDA actions, how these connected devices can be exploited by hackers, and what medical device makers can learn from industries that have already faced these issues.
